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Dear Sir:
With interest, we have read the article by Roberto Rey-Dios
and Aaron A. Cohen-Gadol: Technical principles and neuro-
surgical applications of fluorescein fluorescence using a
microscope-integrated fluorescence module (Acta Neurochir.
[2013] 155:701–706).
The authors explore new technology proffered by the
Zeiss company, the YELLOW 560 system for neurosurgery
using fluorescein.
The images obtained for vascular surgery appear impres-
sive. In contrast to the Zeiss INFRARED 800 or FLOW 800
systems, which use indocyanine green (ICG), fluorescein is
directly visible within the vessels, which the surgeon can
inspect and directly manipulate. FLOW 800, on the other
hand, gives an image only available on the screen of the
microscope, but has the advantage of giving semi-
quantitative information that has been explored by our and
other groups [2, 3].
Years ago, before we had access to the INFRARED 800
system, we used fluorescein for vascular surgery with the Zeiss
Blue 400 system. This system gives violet blue illumination
light (375–440 nm), and thus covers part of the excitation
spectrum of fluorescein. The BLUE 400 emission filter effec-
tively allows visualization of fluorescein, thus giving similar
information to the YELLOW 560 system without additional
costs to neurosurgeons with access to BLUE 400 technology
(Fig. 1). Although the background is blue, the fluorescence is
very vivid and the contrast of vasculature to brain very high,
providing all the information one requires in vascular surgery.
Surgeons may wish to explore this possibility.
On the other hand, we are somewhat worried about the
reintroduction of fluorescein for oncological surgery, which
our group abandoned many years ago, prior to the develop-
ment of 5-ALA. The first description was in 1948 by Moore
[4], who already commented that “edematous tissue does
fluoresce, but to a lesser degree “.
Fluorescein enters the tumor via a broken down blood–
brain barrier and is unspecific. Wherever there is blood there
will be fluorescein, especially in the zone of edema or in any
areas of the brain with surgical injury. This is actually well
illustrated by the authors’ own images, 1 d and 1 e, and we
wonder why these images are not commented on to this end.
The image was obtained during surgery for a metastasis and
clearly shows that fluorescence marks a much larger area of
cortex adjacent to the metastasis in image 1 e after surgical
intervention, than in image 1 d, and it appears this is related
to surgical trauma. This was our personal experience many
years ago.
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We acknowledge greater ease of application of fluores-
cein, which needs only be injected, but if researchers would
like to again follow this path, much work needs to be done
regarding timing, dose, and most importantly, the positive
predictive value of fluorescence. The investigation of the
positive predictive value of fluorescence should focus on the
end of surgery. At this stage, the most unspecific fluores-
cence will be expected as a consequence of tissue injury and
leakage of fluorescein into adjacent tissue.
Sincerely,
Walter Stummer, Münster
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Fig. 1 Top: intra-operative imaging of anterior communicating artery
aneurysm clipped via a left transorbital keyhole approach [1] (ICA
internal carotid artery; A1, A2 A1 and A2-segments of the anterior
cerebral arteries; ON optic nerve). Bottom: Same intra-operative site,
observed using a single bolus injection of fluorescein. The patency of
all vessels is clearly observed (Natrium-Fluorescein®, Alcon,
Germany, 2 ml, 200 mg)
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